Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases
PAF is a potent inflammatory compound known to stimulate the release of various cytokines involved in rheumatic diseases. Elevated blood PAF levels are reported in these patients. We report that serum PAF acetylhydrolase activity (AHA) levels are decreased in patients with rheumatoid arthritis or os...
Saved in:
Main Authors: | P. Vergne, V. Praloran, R. Treves, Y. Denizot |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1997-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1080/09629359791758 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elevated plasma phospholipase A2 and platelet-activating factor acetylhydrolase activity in colorectal cancer
by: Yves Denizot, et al.
Published: (2004-01-01) -
Effect of platelet-activating factor on the growth of human erythroid and
myeloid CD34+ progenitors
by: F. Dupuis, et al.
Published: (1998-01-01) -
Endothelial factors and blood homocysteine level in adolescents with rheumatic diseases
by: T. O. Holovko, et al.
Published: (2024-03-01) -
Estimation of serum calcium levels in apheresis platelet donors
by: P. Arpitha, et al.
Published: (2024-01-01) -
Primer on the Rheumatic Diseases /
Published: (1993)